Weight-loss drugs linked to rare vision loss: Harvard study

No Title

Novo Nordisk (NVO) and Eli Lilly (LLY) shares dip in reaction to a Harvard study that found GLP-1 weight-loss drugs Ozempic and Wegovy could be linked to rare cases of vision loss. Yahoo Finance health reporter Anjalee Khemlani explains the study's findings.


MAGA President

Written by OldTimerNW

RANK: MAGA President

UPVote if you like this

Leave a Reply

Your email address will not be published. Required fields are marked *